Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society

• Bu Kyung Kim,
• Chong Hwa Kim,
• Yong-Ki Min

Affiliations

Bu Kyung Kim

Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea

Chong Hwa Kim

Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea

Yong-Ki Min

Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea